Stay updated on Pembrolizumab in Poor-Prognosis CUP Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study details, indicating the record is inaccessible at this URL.
    Difference
    18%
    Check dated 2026-09-22T23:03:53.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to v3.7.0, indicating a site or template update. No trial-specific text, dates, or eligibility criteria are affected by this change.
    Difference
    0.1%
    Check dated 2026-09-15T21:47:09.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.6, replacing the old v3.6.5. This indicates a small update to the page versioning rather than a substantive change to study information.
    Difference
    0.1%
    Check dated 2026-09-01T18:26:07.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.4 to v3.6.5 on the page, indicating a subsequent software update to the ClinicalTrials.gov entry.
    Difference
    0.1%
    Check dated 2026-08-11T22:55:20.000Z thumbnail image
  6. Check
    77 days ago
    Change Detected
    Summary
    The additions expand and clarify the study's secondary and primary endpoints, including RECIST 1.1-based response definitions, duration of response, disease control, and the time frames for OS and PFS. They also specify the assessment of adverse events and the overall analytic time horizons used in the study.
    Difference
    2%
    Check dated 2026-07-21T23:05:44.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Results posted and completion details updated, with enrollment recorded as 33. A PDF of the Study Protocol and Statistical Analysis Plan has been added under Study Documents.
    Difference
    3%
    Check dated 2026-07-07T14:53:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Poor-Prognosis CUP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.